Sherrie Bhoori

机构：Fondazione IRCCS Istituto Nazionale dei Tumori · ORCID：0000-0002-2837-6398

发表论文 142 篇 · 总被引 9575 次 · h-index 37

代表论文

• Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis (2024 · Journal of Hepatology · 被引 101)
• Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation (2024 · Journal of Hepatology · 被引 63)
• Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma (2025 · Journal of Hepatology · 被引 23)
• Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma (2024 · JHEP Reports · 被引 21)
• Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study (2024 · Transplant International · 被引 13)
• Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study (2024 · JHEP Reports · 被引 13)